ID
38666
Descripción
Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma
Palabras clave
Versiones (4)
- 5/11/18 5/11/18 -
- 5/11/18 5/11/18 -
- 4/12/18 4/12/18 -
- 30/10/19 30/10/19 - Sarah Riepenhausen
Titular de derechos de autor
GSK group of companies
Subido en
30 de octubre de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837
Concomitant Medications Form
- StudyEvent: ODM
Similar models
Concomitant Medications Form
- StudyEvent: ODM
C1522508 (UMLS CUI-2)
C0013227 (UMLS CUI [1,2])
C0947323 (UMLS CUI [1,2])
C0033080 (UMLS CUI [1,2])
C0013231 (UMLS CUI [2])
C0808070 (UMLS CUI [1,2])
C2603343 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C0549178 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2])
C0439810 (UMLS CUI [1,2])
C0349790 (UMLS CUI [1,2])
C0884980 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Sin comentarios